Monte Rosa Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Ali Behbahani(15.4%),New Enterprise Associates 17, L.P.(15.2%)等
Monte Rosa Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-T. ROWE PRICE ASSOCIATES, INC.(10.2%)
Monte Rosa Therapeutics | SC 13G:超過5%持股股東披露文件-Baker Bros. Advisors LP(9.8%),Baker Bros. Advisors (GP) LLC(9.8%)等
Monte Rosa Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Cormorant Global Healthcare Master Fund, LP(0.00%),Cormorant Global Healthcare GP, LLC(0.00%)等
Monte Rosa Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-BlackRock, Inc.(4.7%)
Monte Rosa Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-T. ROWE PRICE ASSOCIATES, INC.(9.9%)
Monte Rosa Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Avoro Capital Advisors LLC(9.1%),Behzad Aghazadeh(9.1%)
Monte Rosa Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-FMR LLC(11.056%),Abigail P. Johnson(11.056%)
Monte Rosa Therapeutics | 4:持股變動聲明-高管 Dunn Edmund
Monte Rosa Therapeutics | 4:持股變動聲明-高管 Wallace Owen B.
Monte Rosa Therapeutics | 4:持股變動聲明-高管 Warmuth Markus
Monte Rosa Therapeutics | 4:持股變動聲明-高管 Jones Jullian G
Monte Rosa Therapeutics | 4:持股變動聲明-高管 Janku Filip
Monte Rosa Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Versant Venture Capital VI, L.P.(13.7%),Versant Ventures VI GP, L.P.(13.7%)等
Monte Rosa Therapeutics | 3:首次持股聲明-首席會計師 Dunn Edmund
Monte Rosa Therapeutics | 4:持股變動聲明-董事 Manning Anthony M.
Monte Rosa Therapeutics | 3:首次持股聲明-董事 Manning Anthony M.
Monte Rosa Therapeutics | 4:持股變動聲明-董事 Behbahani Ali
Monte Rosa Therapeutics | 4:持股變動聲明-董事 Skvarka Jan
Monte Rosa Therapeutics | 4:持股變動聲明-董事 Siu Christine
暫無數據